Ameriprise’s Zymergen Inc. Common Stock ZY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-41,912
Closed -$122K 4031
2022
Q1
$122K Sell
41,912
-1,630
-4% -$6.92K ﹤0.01% 3830
2021
Q4
$292K Buy
43,542
+2,290
+6% +$22.2K ﹤0.01% 3682
2021
Q3
$543K Buy
41,252
+1,289
+3% +$27.3K ﹤0.01% 3373
2021
Q2
$1.6M Buy
+39,963
New +$1.58M ﹤0.01% 3013

Other funds holding ZY

Ameriprise's ZY Position: Q2 2022 in Review

Ameriprise sold out of Zymergen Inc. Common Stock (ZY) in Q2 2022, closing a stake of 41,912 shares — an estimated $122K sold.

Ameriprise first reported a position in ZY in Q2 2021 and held it in 4 quarters. The position peaked at $1.6M in Q2 2021. 81 funds tracked by Wall St. Rank hold ZY as of Q2 2022.

  • Ameriprise reported no remaining Zymergen Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Ameriprise sold 41,912 Zymergen Inc. Common Stock shares in Q2 2022, an estimated $122K.
  • Ameriprise first reported a position in Zymergen Inc. Common Stock in Q2 2021 and held it in 4 quarters.
  • Ameriprise's Zymergen Inc. Common Stock position peaked at $1.6M in Q2 2021.
  • 81 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q2 2022.

Based on Ameriprise's 13F filing for Q2 2022, filed 15 Aug 2022.